Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Complementation Tests00:49

Complementation Tests

A complementation test is a simple cross to identify whether the two mutations are located on the same gene or different genes. It was first performed by Edward Lewis in the 1940s while working on fruit flies. He developed the test to identify the location and arrangement of different mutations on chromosomes.
Organisms heterozygous for different mutations are crossed pairwise in all combinations. If present on different genes, the mutations can complement each other by providing the missing...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A 3D Graphene Oxide Model Reveals Fine Particulate Matter Induced Cell Cycle Dysregulation in Neural Stem Cells.

Toxics·2026
Same author

RAAVioli: A comprehensive approach to characterizing AAV vector integrations and rearrangements.

Molecular therapy. Advances·2026
Same author

The prevalence and associated factors of oral frailty in older Chinese patients with chronic conditions: a systematic review and meta-analysis.

BMC geriatrics·2026
Same author

Modulation of Iron-Induced Glucose Metabolic Reprogramming Alleviates Retinal Pigment Epithelial Cell Senescence.

Investigative ophthalmology & visual science·2026
Same author

A clinically relevant retrograde intraductal injection (RIDI) for lipid nanoparticles-mediated base editing in the pancreas.

Nanomedicine : nanotechnology, biology, and medicine·2026
Same author

Short-term effect of PM<sub>2.5</sub> exposure on pediatric neurological outpatient visits in Shijiazhuang China 2013-2021.

Scientific reports·2026

Related Experiment Video

Updated: Jun 24, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Validation of Fanconi anemia complementation Group A assignment using molecular analysis.

Nabil N Moghrabi1, Monique A Johnson, Marvin J Yoshitomi

  • 1Department of Molecular and Medical Genetics, Clinical Genetics Laboratories, Oregon Health & Science University, 3181 S.W. Sam Jackson Park Road, Portland, OR 97239, USA.

Genetics in Medicine : Official Journal of the American College of Medical Genetics
|April 16, 2009
PubMed
Summary
This summary is machine-generated.

Fanconi anemia complementation group assignment to Group A (FANCA) was validated in a clinical setting. A rapid molecular testing strategy efficiently identified FANCA mutations in Fanconi anemia patients.

More Related Videos

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Related Experiment Videos

Last Updated: Jun 24, 2026

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
05:58

Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format

Published on: August 20, 2018

Rare Event Detection Using Error-corrected DNA and RNA Sequencing
10:36

Rare Event Detection Using Error-corrected DNA and RNA Sequencing

Published on: August 3, 2018

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells
09:16

Investigation of the Transcriptional Role of a RUNX1 Intronic Silencer by CRISPR/Cas9 Ribonucleoprotein in Acute Myeloid Leukemia Cells

Published on: September 1, 2019

Area of Science:

  • Genetics
  • Molecular Biology
  • Hematology

Background:

  • Fanconi anemia (FA) is a heterogeneous chromosomal breakage disorder with variable clinical presentation.
  • Accurate complementation group assignment is crucial for efficient molecular diagnosis of FA.
  • Previous methods for FA complementation group assignment lacked clinical validation.

Purpose of the Study:

  • To confirm the accuracy of Fanconi anemia complementation group assignment to Group A (FANCA).
  • To develop a rapid mutation detection strategy for FANCA.
  • To ensure efficient capture of all FANCA mutations for improved molecular diagnosis.

Main Methods:

  • Fibroblast samples from 29 Fanconi anemia patients were used for breakage analysis.
  • Denaturing high-pressure liquid chromatography, sequencing, and multiplex ligation-dependent probe amplification were employed to analyze FANCA sequences.
  • cDNA sequencing and analysis of other FA genes (FANCC, G, E, F) were performed for patients with unidentified mutations.

Main Results:

  • The study analyzed 56 putative mutant alleles.
  • A pathogenic mutation in FANCA was identified in 89% of the studied alleles.
  • Eight novel FANCA mutations were discovered.

Conclusions:

  • Fanconi anemia complementation group assignment to Group A was successfully validated in a clinical laboratory.
  • The developed FANCA rapid molecular testing strategy is effective for clinical application.
  • This strategy facilitates efficient molecular diagnosis of Fanconi anemia Group A.